SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-11-052449
Filing Date
2011-10-11
Accepted
2011-10-11 16:05:27
Documents
3
Period of Report
2011-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd323725.htm 8-K 14323
2 PRESS RELEASE, DATED OCTOBER 7, 2011, TITLED "DYNAVAX REPORTS DIABETIC SUBSET DA rrd323725_36194.htm EX-99 7864
3 PRESS RELEASE, DATED OCTOBER 10, 2011, TITLED "DYNAVAX REPORTS POSITIVE IMMUNOGE rrd323725_36195.htm EX-99 10400
  Complete submission text file 0001181431-11-052449.txt   33689
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 111135598
SIC: 2834 Pharmaceutical Preparations